Skip to content
DataLookout
Menu

VIMNCT07317921

Validating IAAO for Muscle Outcomes

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 9 words Show 5 more changesShow less
    • Primary endpoints: details revised at 4 of 4 entries
    • Enrollment closed, study ongoing
    • Study completion pushed from May 20, 2026 to Dec 20, 2026
    • Primary completion date changed from estimate of Mar 20, 2026 to Apr 17, 2026
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Phenylalanine excretion (umol/kg/h)
Timeframe: 6.5 hours
Phenylalanine oxidation (umol/kg/h)
Timeframe: 6.5 hours
Myofibrillar protein synthesis (%/hr)
Timeframe: 6.5 hours
Sarcoplasmic protein synthesis (%/hr)
Timeframe: 6.5 hours

Arms and interventions

Protein + Stable Isotope Tracer BeverageExperimental

Participants will consume 12 half-hourly (6 hours) isoenergetic, isonitrogenous beverages containing 0.9g/kg fat-free mass/day protein. Drinks will be enriched with stable isotopes \[2H5\]Phenylalanine and \[1-13C\]Phenylalanine, which will respectively allow for determination of muscle protein synthesis and whole-body protein synthesis over the subsequent 6 hours of feeding.

Dietary supplements: Protein + Stable Isotope Tracer Beverage

Sites

1 site in 1 country

  • Kinesiology & Physical EducationToronto, Ontario, Canada